CLINICAL_TRIALS
trial_result
· 2022-01-05
Clinical Trial Update: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) [Phase 2]
Summary
Phase 2 trial update evaluating combined immunochemotherapy in patients with T-cell prolymphocytic leukemia (T-PLL) has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: German CLL Study Group | Conditions: T-cell-prolymphocytic Leukemia | Phase 2 | Status: COMPLETED